Chairman Jiang Xiaomeng Elected New President
Release time:
2020-08-14
Provincial Building Materials Industry Association Member Conference Held in Jin
Chairman Jiang Xiaomeng Elected New President
News 3# October 25 , Zhejiang Building Materials Industry Association Fifth Member Conference and Fifth First Council Held in Jinhua. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was elected as the new president at this meeting.
Zhejiang Building Materials Industry Association has been established 28 . In the past 5 years, the Provincial Building Materials Industry Association has adhered to the requirements of "stabilizing growth, adjusting structure, and increasing benefits" and insisted on doing a good job in industry services. It has curbed the decline in benefits, promoted supply-side reforms, and eliminated production capacity, and made up for shortcomings. Many efforts have been made in increasing benefits to promote the province's building materials industry to achieve rapid development. This year coincides with the change of the meeting. Relevant persons in charge of China Building Materials Federation, Zhejiang Provincial Economic and Information Commission, and Jinhua Municipal Economic and Information Commission attended the meeting and gave speeches to analyze the current situation of the domestic building materials industry and put forward suggestions for the future development of the industry. Ye Ziyu, deputy director of Jinhua Municipal Commission of economy and information technology, specially introduced the construction concept of "three corridors" in Jinhua, and welcomed building materials entrepreneurs in the province to invest in Jinhua.
This meeting held a general election for the leadership of the association. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was elected as the new president. In his inaugural speech, Jiang Xiaomeng pointed out that Zhejiang is a major province in the national building materials industry, and cement, new wall, thermal insulation materials and other industries are in a leading position in China. At present, the state vigorously advocates "supply-side structural reform", resolves excess capacity, and does a good job in energy conservation, emission reduction, transformation and upgrading. With the strong support of governments at all levels, Zhejiang building materials enterprises should make active efforts to do a good job in this article. Industry associations should actively build a platform for communication and exchange between members and between enterprises and government departments, support each other, go out to sea in groups, form a joint force, and seek common development; they should continue to give full play to the advantages of expert resources, take the initiative to provide member units with information services such as economic information, technological innovation and management consulting, promote the management technology innovation of member enterprises, and improve the level of management technology. Promote the overall upgrading of building materials enterprises in Zhejiang Province. The
meeting also specially invited Gao Hai, director of the Shanghai Cooperation International Center of the Shanghai Cooperation Organization, to give a special report on the cooperation and development of the building materials industry along the SCO "Belt and Road Initiative" route. (Fu Yiwu
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page